1. Home
  2. IMMP vs QRHC Comparison

IMMP vs QRHC Comparison

Compare IMMP & QRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immutep Limited

IMMP

Immutep Limited

SELL

Current Price

$3.36

Market Cap

31.5M

Sector

Health Care

ML Signal

SELL

Logo Quest Resource Holding Corporation

QRHC

Quest Resource Holding Corporation

SELL

Current Price

$1.19

Market Cap

31.5M

Sector

Utilities

ML Signal

SELL

Company Overview

Basic Information
Metric
IMMP
QRHC
Founded
1987
N/A
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
31.5M
IPO Year
2012
2008

Fundamental Metrics

Financial Performance
Metric
IMMP
QRHC
Price
$3.36
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $3.25
AVG Volume (30 Days)
30.6K
★ 41.3K
Earning Date
09-01-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $138,346,327.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.00
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.26
$0.81
52 Week High
$5.36
$2.41

Technical Indicators

Market Signals
Indicator
IMMP
QRHC
Relative Strength Index (RSI) 49.75 46.07
Support Level $3.06 $1.01
Resistance Level $3.55 $1.40
Average True Range (ATR) 0.34 0.13
MACD -0.05 0.01
Stochastic Oscillator 41.09 30.11

Price Performance

Historical Comparison
IMMP
QRHC

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.

Share on Social Networks: